Unknown

Dataset Information

0

A Therapeutic Silencing RNA Targeting Hepatocyte TAZ Prevents and Reverses Fibrosis in Nonalcoholic Steatohepatitis in Mice.


ABSTRACT: Nonalcoholic steatohepatitis (NASH) is emerging as a major public health issue and is associated with significant liver-related morbidity and mortality. At present, there are no approved drug therapies for NASH. The transcriptional coactivator with PDZ-binding motif (TAZ; encoded by WW domain-containing transcription regulator 1 [WWTR1]) is up-regulated in hepatocytes in NASH liver from humans and has been shown to causally promote inflammation and fibrosis in mouse models of NASH. As a preclinical test of targeting hepatocyte TAZ to treat NASH, we injected stabilized TAZ small interfering RNA (siRNA) bearing the hepatocyte-specific ligand N-acetylgalactosamine (GalNAc-siTAZ) into mice with dietary-induced NASH. As a preventative regimen, GalNAc-siTAZ inhibited inflammation, hepatocellular injury, and the expression of profibrogenic mediators, accompanied by decreased progression from steatosis to NASH. When administered to mice with established NASH, GalNAc-siTAZ partially reversed hepatic inflammation, injury, and fibrosis. Conclusion: Hepatocyte-targeted siTAZ is potentially a novel and clinically feasible treatment for NASH.

SUBMITTER: Wang X 

PROVIDER: S-EPMC6719739 | biostudies-literature | 2019 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

A Therapeutic Silencing RNA Targeting Hepatocyte TAZ Prevents and Reverses Fibrosis in Nonalcoholic Steatohepatitis in Mice.

Wang Xiaobo X   Sommerfeld Mark R MR   Jahn-Hofmann Kerstin K   Cai Bishuang B   Filliol Aveline A   Remotti Helen E HE   Schwabe Robert F RF   Kannt Aimo A   Tabas Ira I  

Hepatology communications 20190723 9


Nonalcoholic steatohepatitis (NASH) is emerging as a major public health issue and is associated with significant liver-related morbidity and mortality. At present, there are no approved drug therapies for NASH. The transcriptional coactivator with PDZ-binding motif (TAZ; encoded by WW domain-containing transcription regulator 1 [<i>WWTR1</i>]) is up-regulated in hepatocytes in NASH liver from humans and has been shown to causally promote inflammation and fibrosis in mouse models of NASH. As a p  ...[more]

Similar Datasets

| S-EPMC5226184 | biostudies-literature
| S-EPMC6822168 | biostudies-literature
| S-EPMC4677570 | biostudies-literature
| S-EPMC5986206 | biostudies-literature
| S-EPMC7135973 | biostudies-literature
| S-EPMC6357833 | biostudies-other
| S-EPMC5970222 | biostudies-literature
| S-EPMC5752377 | biostudies-literature
| S-EPMC6997423 | biostudies-literature
| S-EPMC6437635 | biostudies-literature